Objectives: Tear trough: agarose gel treatment
To report safety and patient satisfaction outcomes of AGAROSE GEL 1% for correction of tear trough
Introduction: The tear trough deformity is commonly requested for correction, most often by filler injections. However, the tear trough remains difficult to treat due to its complex anatomy, a variety of other concurrent deformities, and the high risk of complications.
AGAROSE GEL filler can be safely used as a soft-tissue filler for correction of infraorbital hollowing. It has a high overall patient satisfaction profile among patients.
Materials / method: This was a retrospective observational study performed at a private ambulatory of aesthetic medicine and surgery practice. Participants were all patients 21 to 85 years old who presented to our practice and underwent agarose gel 1 % treatment for correction of tear trough as a singular intervention from February 2019 to July 2021.
Interventions: Injection of Agarose gel 1% to the tear trough, nasojugal fold, and/or palpebromalar groove.
Main outcomes and measures: Primary outcome measures include the number of recorded short- and long-term adverse events, need for additional treatment, and
Results: Results: A total of 202 eyes were treated in 101 patients with a mean follow-up of 12 months. Patients were principally female (90 [89%]) with an average age of 54 years (range, 21-85 years). Most patients (99) had Fitzpatrick grade 1 to 4 skin type (98%) and had an infraorbital hollows score of 2 to 4 (89 [88%]). The average initial treatment volume was 0,5 mL with 18 patients (18%) requiring additional treatment within 3 months. The average time until additional treatment was 35.7 days. Adverse effects include bruising (in 10 [10%], contour irregularities (2 [2%]),swelling (7[7%]),
Tyndal 0
Conclusion: Hyaluronidase never was required . Forty-one patients completed the FACE-Q Satisfaction With Eyes survey, and 42 patients completed the FACE-Q Satisfaction With Decision survey (41% and 42%). Overall mean (SD) patient satisfaction (based on FACE-Q scores) was 71.1% (27.3) and 65.6% (31.3), respectively
Conclusions and relevance: agarose gel 1% has a high patient satisfaction profile and and good safety profile for the correction of tear trough.
Divulgação de informações
Você recebeu algum patrocínio para sua pesquisa neste tema?
Não
Você recebeu algum tipo de honorário, pagamento ou outra forma de compensação por seu trabalho neste estudo?
Não
Você possui relação financeira com alguma entidade que possa competir com os medicamentos, materiais ou instrumentos abordados no seu estudo?
Não
Você detém ou pediu a registro de patente para algum dos instrumentos, medicamentos ou materiais abordados no seu estudo?
Não
Este trabalho não recebeu nenhum patrocínio direto ou indireto. O mesmo está sob a própria responsabilidade do seu autor.